Gut and Oral Microbiome of GDM Patients During Pregnancy

Sponsor
Peking Union Medical College Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT04420507
Collaborator
Chinese Academy of Medical Sciences (Other)
163
1
35.5
4.6

Study Details

Study Description

Brief Summary

The study aimed to clarify the characteristics of the intestinal and oral microbiome of Gestational Diabetes Mellitus(GDM) patients during the whole pregnancy, try to clarify the relationship between the microbiome and GDM.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    The aims of the study are to reveal the possibly natural change of the gut and oral microbiome of GDM patients during pregnancy, and to explorer whether GDM happened during pregnancy are associated with the maternal gut and oral microbiomes. As a perspective cohort study, the researchers will recruit pregnant women in early pregnancy(before 13 gestational weeks)and following the pregnancies till delivery. The stool samples and saliva samples of the recruits will be collected in 914,2428 and 3237 gestational weeks separately. The investigators will also perform oral examination between 2428 weeks and sample subgingival plaque for test. Overall, all samples will be examined use 16S rRNA gene sequencing to analyze microbiome. And part of the samples of GDM patients will be analyzed using metagenomics. Combine with the pregnancy outcomes, the differences of gut and oral microbiome between GDM patients and healthy women will be expected, as well as the natural change during pregnancy.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    163 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Different Characteristics of Gut and Oral Microbiota of Women With Gestational Diabetes Mellitus
    Actual Study Start Date :
    May 15, 2017
    Actual Primary Completion Date :
    Apr 30, 2019
    Actual Study Completion Date :
    Apr 30, 2020

    Arms and Interventions

    Arm Intervention/Treatment
    GDM group

    pregnant women who are diagnosed after 75g OGTT test between 24~27+6 gestational weeks

    health group

    pregnant women who pass the 75g OGTT test and aren't diagnosed as GDM, and also don't have any other conditions, like hypertensive disorders, IBD, gastrointestinal ulcer, and so on.

    Outcome Measures

    Primary Outcome Measures

    1. the gut and oral microbiome of GDM patients during pregnancy [the first trimester(9-14 gestational weeks), the second trimester (24-28 gestational weeks) and the third trimester(32-37 gestational weeks)]

      The composition and species of gut and oral microbiome of GDM patients,separately in the first trimester(9-14 gestational weeks), the second trimester (24-28 gestational weeks) and the third trimester(32-37 gestational weeks).

    2. the gut and oral microbiome of healthy pregnant women [the first trimester(9-14 gestational weeks), the second trimester (24-28 gestational weeks) and the third trimester(32-37 gestational weeks)]

      The composition and species of gut and oral microbiome of healthy pregnant women ,separately in the first trimester(9-14 gestational weeks), the second trimester (24-28 gestational weeks) and the third trimester(32-37 gestational weeks).

    Secondary Outcome Measures

    1. The glucose level during pregnancy [the first trimester(9-14 gestational weeks), the second trimester (24-28 gestational weeks) and the third trimester(32-37 gestational weeks)]

      The fasting blood glucose level and the glycosylated albumin level in the first trimester(9-14 gestational weeks), the second trimester (24-28 gestational weeks) and the third trimester(32-37 gestational weeks). And the result of 75gOGTT test.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    20 Years to 45 Years
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • pregnant women

    • gestational age: before 13+6 weeks

    • regular prenatal care in PUMCH

    Exclusion Criteria:
    • have medical history or current conditions: Gastrointestinal disorders, for example: Gastritis, gastric ulcer, inflammatory bowel disease; Hypertension; Diabetes; SLE or other severe CTD;

    • pregnant, combine with malignancy diseases;

    • pregnant, can't ensure regular prenatal check.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Peking Union Medical College Hospital Beijing Beijing China 100730

    Sponsors and Collaborators

    • Peking Union Medical College Hospital
    • Chinese Academy of Medical Sciences

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Peking Union Medical College Hospital
    ClinicalTrials.gov Identifier:
    NCT04420507
    Other Study ID Numbers:
    • Gut and oral microbiome of GDM
    First Posted:
    Jun 9, 2020
    Last Update Posted:
    Jun 9, 2020
    Last Verified:
    Mar 1, 2020
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Peking Union Medical College Hospital
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jun 9, 2020